Growth Metrics

Day One Biopharmaceuticals (DAWN) Change in Acquisitions & Divestments (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Change in Acquisitions & Divestments for 4 consecutive years, with -$425.8 million as the latest value for Q3 2025.

  • For Q3 2025, Change in Acquisitions & Divestments fell 458.55% year-over-year to -$425.8 million; the TTM value through Sep 2025 reached -$28.6 million, down 126.47%, while the annual FY2024 figure was $79.4 million, N/A changed from the prior year.
  • Change in Acquisitions & Divestments was -$425.8 million for Q3 2025 at Day One Biopharmaceuticals, down from $264.8 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $264.8 million in Q2 2025, with the low at -$425.8 million in Q3 2025.
  • Historically, Change in Acquisitions & Divestments has averaged $6.6 million across 4 years, with a median of $33.9 million in 2022.
  • The largest annual shift saw Change in Acquisitions & Divestments tumbled 1470.0% in 2023 before it surged 454.17% in 2025.
  • Over 4 years, Change in Acquisitions & Divestments stood at -$20.0 million in 2022, then tumbled by 1270.0% to -$274.0 million in 2023, then surged by 89.57% to -$28.6 million in 2024, then crashed by 1389.26% to -$425.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were -$425.8 million in Q3 2025, $264.8 million in Q2 2025, and $161.0 million in Q1 2025.